Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana (ORPAL)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02903706 |
Recruitment Status :
Completed
First Posted : September 16, 2016
Last Update Posted : September 16, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Malaria is the most widespread parasitic illness in the world, and it is endemic to Guiana. Although the number of cases has decreased since 2005, sources of infection still remain, particularly within illegal gold mines. These malaria carriers/sufferers often use self-medication to deal with malaria symptoms, resulting in a risk of resistance to anti-malarial treatments, and particularly to artemisinine. The mobility of this population across the Guiana Shield increases both the risk of malaria spreading and the resistance of this illness to treatment in the region, and puts the population at risk of new outbreaks of this disease despite the great efforts put into anti-malarial policy in this region.
Fighting malaria within this population is therefore a dual public health challenge: on the one hand, make it possible for the WHO to eliminate malaria from the Guiana Shield by 2017, on the other to limit resistance to artemisinine in this region. However, Guiana's particular context - namely the illegal status of gold mines and the difficult geographical access, the Harpie military operations, the illegality of carrying out malarial diagnosis tests and treating cases without the presence of a health professional - prevents us from achieving this goal using the same tools as our neighbours in Suriname, whose " Looking for Gold, Finding Malaria " programme was a success.
A better understanding of the malarial epidemiology in this population will enable us to propose innovative, more adapted measures to combat malaria within these guyanese populations. This is an transversal, multicentric observational study.
Condition or disease | Intervention/treatment |
---|---|
Malaria Epidemiology | Other: Measure of Plasmodium prevalence (PCR) |

Study Type : | Observational |
Actual Enrollment : | 421 participants |
Observational Model: | Case-Crossover |
Time Perspective: | Cross-Sectional |
Official Title: | Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana |
Study Start Date : | October 2014 |
Actual Primary Completion Date : | June 2015 |
Actual Study Completion Date : | June 2015 |
- prevalence of malaria positive individuals (symptomatic or not symptomatic) [ Time Frame: 1 month ]every participant gives a capillary blood specimen which is then screened for malaria using PCR in order to obtain a prevalence of malaria positive individuals (symptomatic or not symptomatic)
- Microscopy: thick and thin smear [ Time Frame: 1 month ]Each participant is screen for malaria using classic microscopy on thin and thick smears in order to obtain a prevalence of malaria positive individuals and to evaluate parasite quantities, and gametocyte carriage (transmission potential). If either thin or thick smears are positive then the patient is estimated to have smear positive malaria.
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- works on a gold mining site in French Guiana
- has been at the resting site for less than seven days
- is over the age of 18
- accepts to take part in this study
Exclusion Criteria:
- refuses to take part in the study
- is under the age of 18
Responsible Party: | Centre Hospitalier de Cayenne |
ClinicalTrials.gov Identifier: | NCT02903706 |
Other Study ID Numbers: |
ORPAL |
First Posted: | September 16, 2016 Key Record Dates |
Last Update Posted: | September 16, 2016 |
Last Verified: | September 2016 |
gold miners plasmodium carriers artemisinine resistance |
Malaria Protozoan Infections Parasitic Diseases Infections Vector Borne Diseases |